DoW Autism Clinical Trial Award

Funding Opportunity Number: HT942526ARPCTA

About the Opportunity

The fiscal year 2026 (FY26) Autism Research Program (ARP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of autism. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.

Focus Areas

Applications are strongly encouraged to address one of the FY26 ARP Clinical Trial Award Areas of Interest.

Eligibility

• Open to any type of entity, subject to any clarification in the "Additional Information on Eligibility" section.

Program Features

• Partnering Principal Investigator (PI) Option for Early-Career Investigator: The FY26 Clinical Trial Award offers a higher level of funding for applications proposing to partner an experienced PI (i.e., Initiating PI) with an Early-Career Investigator (i.e., Partnering PI) pursuing a career in autism clinical trial research.
• Community Collaborations: Submissions must include community collaborations to optimize research impact. Research teams are required to establish and utilize effective and equitable collaborations with community members (e.g., Autistic individuals, caregivers, representatives of community-based organizations) to maximize the translational and impact potential of the proposed research. Applications must name at least one community partner who will provide advice and consultation throughout the planning and implementation of the research project. Interactions should be well-integrated and ongoing, not limited to attending seminars or semi-annual meetings (see Community Collaboration Plan).

Funding Details

• Estimated Total Program Funding: $3,250,000
• Expected Number of Awards: 1
• Assistance Listing: 12.420 -- Military Medical Research and Development
• Cost Sharing or Matching Requirement: No

Key Dates

• Posted Date: May 21, 2026
• Current Closing Date for Applications: October 22, 2026
• Archive Date: November 21, 2026

Contact Information

For assistance, contact the eBRAP Help Desk:

• Phone: 301-682-5507
• Email: help@eBRAP.org